Welcome to industryreportstore.com

Browse the latest reports in the Company Profiles industry below

3616 Item(s)

Page 1 of 362

  1. Pozen, Inc. (POZN) - Financial and Strategic SWOT Analysis Review more info

    Pozen, Inc. (Pozen) is a progressive pharmaceutical company. It develops combination therapies for various therapeutic areas with particular focus on pain and pain related conditions. The company's products, in various stages of development are for the treatment of migraine, chronic pain, cardiovascular and gastrointestinal diseases. Pozen's commercial products include, Treximet, indicated for the treatment of migraine attacks, with or without aura, in adults; and Vimovo, to provide relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis, and to minimize the risk of developing NSAID-associated gastric ulcers.
    By: GlobalData
    , Published: Apr-2013
    , Product code: GDPH81713FSA
    PAGES: 47 TABLES: 24 FIGURES & CHARTS: 6
    $125.00
  2. Sophiris Bio, Inc. (SHS) - Financial and Strategic SWOT Analysis Review more info

    Sophiris Bio, Inc. (Sophiris), formerly Protox Therapeutics Inc., is a biopharmaceutical company. It focuses on the research, development and commercialization of products for the treatment of urological diseases, such as benign prostatic hyperplasia (BPH), prostate cancer, prostatitis, solid tumors (Renal Cell Carcinoma), bladder cancer and recurrent glioblastoma. Sophiris’s lead drug candidate, PRX302, is under late stage development of the randomized, double-blind, placebo controlled Phase IIb trial for BPH. It plans to begin Phase III trial by the end of 2012. Besides, the PRX302 is under phase IIa clinical trial for the treatment of locally recurrent prostate cancer.
    By: GlobalData
    , Published: Apr-2013
    , Product code: GDPH82545FSA
    PAGES: 41 TABLES: 23 FIGURES & CHARTS: 6
    $125.00
  3. WellPoint, Inc. (WLP) - Financial and Strategic SWOT Analysis Review more info

    WellPoint, Inc. (WellPoint) is a health benefits company, which offers managed healthcare related products and services. The company offers a range of products including preferred provider organization (PPO) products, consumer driven health plans (CDHPs), traditional indemnity products, health maintenance organization (HMO) products, point-of-service (POS) products, administrative services, BlueCard, senior plans, individual plans, Medicaid plans, pharmacy products, life insurance, disability programs, behavioral health programs, long-term care insurance, vision services, and dental plans, among others.
    By: GlobalData
    , Published: Apr-2013
    , Product code: GDPH25012FSA
    PAGES: 48 TABLES: 22 FIGURES & CHARTS: 4
    $125.00
  4. Bachem Holding AG (BANB) - Financial and Strategic SWOT Analysis Review more info

    Bachem Holding AG (Bachem) is a technology-based biochemical company. It develops and manufactures peptides and complex organic molecules including active pharmaceutical ingredients and biochemicals for research purposes. Bachem's portfolio consists of about 156 preclinical and clinical phase products. These products and services include peptides indicated for the treatment of various conditions such as central nervous system disorders, metabolic disorders, cancer and infectious diseases, among others; research ingredients; new chemical entities; and generics. Bachem offers its products and services to the pharmaceutical and biotechnology industries.
    By: GlobalData
    , Published: Apr-2013
    , Product code: GDPH124741FSA
    PAGES: 31 TABLES: 21 FIGURES & CHARTS: 4
    $125.00
  5. Corcept Therapeutics Incorporated (CORT) - Financial and Strategic SWOT Analysis Review more info

    Corcept Therapeutics Incorporated (Corcept) is a research focused pharmaceutical company. It carries out discovery, development, ing and commercializing innovative therapeutics in the areas of psychiatric and metabolic diseases. The company focuses on developing drugs for the treatment of psychiatric disorders such as severe psychotic depression and metabolic diseases such as antipsychotic-induced weight gain mitigation.
    By: GlobalData
    , Published: Apr-2013
    , Product code: GDPH63419FSA
    PAGES: 44 TABLES: 23 FIGURES & CHARTS: 6
    $125.00
  6. Telik, Inc. (TELK) - Financial and Strategic SWOT Analysis Review more info

    Telik, Inc. (Telik) is a development stage bio pharmaceutical company. It carries out discovery, development and commercialization of novel small molecule drugs for the treatment of cancer and other major diseases. The company's research and development activities are focused on advancing its two most clinical advanced drug candidates, Telintra and Telcyta. Telintra is now at phase II clinical development stage, using for the treatment of blood disorders associated with low blood cell levels, such as neutropenia or anemia.
    By: GlobalData
    , Published: Apr-2013
    , Product code: GDPH66770FSA
    PAGES: 37 TABLES: 23 FIGURES & CHARTS: 6
    $125.00
  7. Auxilium Pharmaceuticals, Inc. (AUXL) - Financial and Strategic SWOT Analysis Review more info

    Auxilium Pharmaceuticals, Inc. (Auxilium) is a specialty biopharmaceutical company with focus on the development and marketing of products for the treatment of urology and sexual health problems to urologists, endocrinologists, rheumatologists, orthopedics general and plastic surgeons, and primary care physicians. It markets two products Testim, for the treatment of hypogonadism and Xiaflex (collagenase clostridium histolyticum) which is a proprietary injectable collagenase enzyme for the treatment of Dupuytren’s contracture in adult patients with a palpable cord.
    By: GlobalData
    , Published: Apr-2013
    , Product code: GDPH27528FSA
    PAGES: 46 TABLES: 24 FIGURES & CHARTS: 6
    $125.00
  8. Questcor Pharmaceuticals, Inc. (QCOR) - Financial and Strategic SWOT Analysis Review more info

    Questcor Pharmaceuticals, Inc. (Questcor Pharma) is a biopharmaceutical company that concentrates on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company’s primary product is H.P. Acthar Gel, an injectable drug used for the treatment of 19 indications including the treatment of proteinuria in idiopathic types of nephrotic syndrome; the treatment of acute exacerbations of multiple sclerosis in adults; and the treatment of infantile spasms in children below two years of age. Questocor also offers Doral (quazepam), a product indicated for the treatment of insomnia. Questcor Pharma is headquartered in California, the US.
    By: GlobalData
    , Published: Apr-2013
    , Product code: GDPH4222FSA
    PAGES: 44 TABLES: 25 FIGURES & CHARTS: 6
    $125.00
  9. Grunenthal GmbH - Strategic SWOT Analysis Review more info

    Grunenthal GmbH (Grunenthal) is a research-based, global pharmaceutical company. The company specializes in the areas of pain therapy, contraception and innovative formulations for established active substances. The company develops, produces and markets pain therapy and gynecology products.
    By: GlobalData
    , Published: Apr-2013
    , Product code: GDPH132572SA
    PAGES: 31 TABLES: 14 FIGURES & CHARTS: 4
    $125.00
  10. Warner Chilcott Plc (WCRX) - Financial and Strategic SWOT Analysis Review more info

    Warner Chilcott Plc (Warner Chilcott) is a UK-based specialty pharmaceutical company. It focuses on women's healthcare, dermatology, gastroenterology and urology segments in North markets. Additionally, the company offers other products including skin cleansers; and therapeutic cream and lotions. Further, it offers next generation ATELVIA products for the treatment of osteoporosis in postmenopausal women and small molecules in preclinical development. Geographically, the company operates in the US, Canada, Puerto Rico, UK, France, Italy and other countries. It has manufacturing facilities in Puerto Rico, Northern Ireland and Germany.
    By: GlobalData
    , Published: Apr-2013
    , Product code: GDPH34115FSA
    PAGES: 42 TABLES: 24 FIGURES & CHARTS: 6
    $125.00

3616 Item(s)

Page 1 of 362